Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.

Participants will gain unparalleled insight into the end-to-end lateral flow assay development process, including design control, material selection, manufacturing considerations, and troubleshooting ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

SYGNIS AG, under the Innova Biosciences (Innova) brand name, a specialist provider of bioconjugation products and services, today announced it has established a partnership with Abingdon Health Ltd ...

Dublin, Dec. 12, 2025 (GLOBE NEWSWIRE) -- The "Lateral Flow Assay Components Market by Type, Application, Technique, End User, and Region - Global Forecast to 2030" has been added to ...

In a recent review published in Nature Reviews Bioengineering, researchers assessed the changing landscape of lateral flow tests (LFTs), and the development of next-generation LFTs based on lessons ...

An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce false results in a recent trial. An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce ...

As a leading global producer of gold nanoparticles, nanoComposix focuses on delivering high-purity, monodisperse nanomaterials to ensure consistent quality and reliable results. 150 nm gold nanoshells ...

Lateral flow tests (LFTs) are widely used across healthcare, food safety and environmental monitoring, providing rapid, on-site results. But challenges with sensitivity, flexibility and usability ...